Conference Program Home
My Program
All Times EDT
Legend:
CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
518
|
Thu, 8/11/2022,
8:30 AM -
10:20 AM
|
CC-204C
|
|
Estimand, Causal Inference, and Other Statistical Considerations in Clinical Trials — Contributed Papers
|
|
Biopharmaceutical Section
|
|
Chair(s): Victoria P Johnson, GSK
|
|
8:35 AM
|
When Estimating Causal Effects, Start by Defining Causal Estimands—Not Estimators
Marie-Abele Bind, Massachusetts General Hospital; Eric Macklin, Massachusetts General Hospital; Donald Rubin, Tsinghua University
|
|
8:50 AM
|
The Inherent Meaningfulness of a Novel Time Component Test (TCT): Combining Evidence Across Outcomes to Measure the Impact of Treatment on Progression Rate in Degenerative Diseases
Nathaniel Hogan, Pentara; Jessie Johnson, Pentara; Newman Knowlton, Pentara; Sean Hennessey, Pentara Corporation; Suzanne Hendrix, Pentara; Samuel Dickson, Pentara
|
|
9:05 AM
|
Selection of Analysis Method for GOS-E in Future TBI Clinical Trials Using Retrospective Data
Yu Wang, University of Kansas Medical Center; Byron Gajewski, University of Kansas Medical Center
|
|
9:20 AM
|
Use of Benefit-Risk, Safety, and Estimand Planning Tools to Optimize Drug Approvability and Labeling
Susan Mayo, Food and Drug Administration, Center for Drug Evaluation
|
|
9:35 AM
|
A Bayesian Framework for Identifying Safety-Signal from Multiple Studies
Adrijo Chakraborty, U.S.Food and Drug Administration; Ram Tiwari, Bristol Myers Squibb
|
|
9:50 AM
|
Bayesian Approach to Principal Stratum in a Clinical Setting
Dominique McDaniel, Drexel University ; Ahmad Hakeem Abdul Wahab, Janssen Pharmaceuticals; Run Zhuang, Purdue University; Arman Sabbaghi, Purdue University
|
|
10:05 AM
|
Connecting P-Values and Posterior Probabilities Through Bayes Factor Bound: A Brief History and Its Application
Xiting Yang, FDA; Greg Maislin, Biomedical Statistical Consulting; Dongfeng Qi, Boston Scientific
|
|
